These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34197472)
1. Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China. Gui T; Chen Z; Chen F PLoS One; 2021; 16(7):e0253493. PubMed ID: 34197472 [TBL] [Abstract][Full Text] [Related]
2. Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study. Dai W; Wang T; Chen L; Qiu Z; Chen P; Chen D BMC Womens Health; 2024 Jul; 24(1):419. PubMed ID: 39049047 [TBL] [Abstract][Full Text] [Related]
3. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [TBL] [Abstract][Full Text] [Related]
4. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. Nayar R; Chhieng DC; Crothers B; Darragh TM; Davey DD; Eisenhut C; Goulart R; Huang EC; Tabbara SO J Am Soc Cytopathol; 2020; 9(4):291-303. PubMed ID: 32565297 [TBL] [Abstract][Full Text] [Related]
5. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds. Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China. Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863 [TBL] [Abstract][Full Text] [Related]
7. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579 [TBL] [Abstract][Full Text] [Related]
8. Primary HPV testing verification: A retrospective ad-hoc analysis of screening algorithms on women doubly tested for cytology and HPV. Tracht J; Wrenn A; Eltoum IE Diagn Cytopathol; 2017 Jul; 45(7):580-586. PubMed ID: 28436211 [TBL] [Abstract][Full Text] [Related]
9. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population]. Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341 [No Abstract] [Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
11. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors. Cox JT; Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506 [TBL] [Abstract][Full Text] [Related]
12. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico. Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J; JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033 [TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450 [TBL] [Abstract][Full Text] [Related]
15. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754 [TBL] [Abstract][Full Text] [Related]
16. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women. Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849 [TBL] [Abstract][Full Text] [Related]
17. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16 Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022 [TBL] [Abstract][Full Text] [Related]
18. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243 [TBL] [Abstract][Full Text] [Related]
19. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting. Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study. Gori S; Battagello J; Gustinucci D; Campari C; Zorzi M; Frayle H; Passamonti B; Sartori G; Bulletti S; Fodero C; Cesarini E; Faggiano R; Del Mistro A BJOG; 2021 Jul; 128(8):1353-1362. PubMed ID: 33326680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]